Sentences with phrase «pharmaceuticals executives in»
The Justice Department charged two former Heritage Pharmaceuticals executives in Philadelphia on Wednesday, Bloomberg reported.
https://www.cnbc.com/
«The last thing we need is to put a pharmaceutical executive in charge of the Department of Health and Human Services.»
Specifically the lives of Nathan, an HIV - negative newcomer, and Sean, his HIV - positive guide to all things ACT UP, who, when they're not drenching pharmaceutical executives in blood - red paint as a reminder of the thousands who'd already died of AIDS by the mid -»90s, fall hopelessly in love.
Not exact matches
John Hammergren, chief executive of pharmaceutical giant McKesson, made a killer $ 131 million in 2012, compared to the paltry $ 40 million that Frank Stronach, Canada's highest paid (ex) CEO, got.
Michael «Mike» Pearson, chairman and chief executive officer of Valeant Pharmaceuticals International Inc., left, speaks as Howard Schiller, former interim chief executive officer and former chief financial officer of Valeant Pharmaceuticals, center, and William «Bill» Ackman, founder and chief executive officer of Pershing Square Capital Management LP, listen during a Senate Special Committee on Aging hearing on Valeant Pharmaceuticals in Washington, D.C., U.S., on Wednesday, April 27, 2016.
His clients include executives and business leaders in a broad range of industries, including all varieties of financial services (securities and commodities trading and sales, banking, investment and hedge funds), automobile manufacturing and sales, professional sports agency, pharmaceuticals, and high technology.
Valeant Pharmaceuticals International chief executive Joseph Papa answers questions from shareholders during their annual general meeting in Laval, Quebec June 14, 2016.
«Together with safe sex practice, early diagnosis, and access to treatment, we expect that PrEP will significantly reduce HIV transmission rates in New Zealand,» Sarah Fitt, the chief executive of New Zealand's public pharmaceutical management agency Pharmac, told Stuff.
The Swiss pharmaceuticals giant Novartis is set to get a new chief executive in the form of Vasant Narasimhan, after Joseph Jimenez announced his upcoming retirement.
Almost all of TGaS's employees are senior - level executives who came to the company after years of experience in the pharmaceutical industry.
When it comes to the big screen, Wall Streeters fall in a category with pharmaceutical manufacturers and oil company executives — untouchably unsympathetic.
It wasn't hard to generate a qualified pool of applicants, he added, because the ongoing M&A frenzy in the pharmaceutical sector has left a lot of competent executives on the sidelines after their companies were acquired.
It's not technology or regulation or any complex system that is blocking more aggressive drug development in the almost half a trillion - dollar U.S. pharmaceutical industry, health executives in the room seemed to agree.
Prior to this, he was Chief Business Officer of Akarna Therapeutics, and negotiated its acquisition by Allergan in 2016 for up to $ 1.2 B. Previously, he served as a senior executive at Ardea Biosciences (acquired by AstraZeneca), Xencor, X-Ceptor Therapeutics (acquired by Exelixis) and Aurora Biosciences (acquired by Vertex Pharmaceuticals).
Bruce brings to Humana a wide range of executive leadership experience in publicly traded and private organizations within a variety of healthcare sectors, including oncology, pharmaceuticals, assisted living / senior housing, home care, physician practice management, surgical centers and dental networks.
Inside Mylan, executives including Bresch all refer to EpiPen as her «baby»: It's Mylan's first billion - dollar drug, reaching $ 1 billion in annual sales in 2014 and 2015 — making it what the pharmaceutical industry calls a «blockbuster.»
The firm's previous chief executive, Joseph Papa, left back in 2016 to see if he could clean up the growing mess at Valeant Pharmaceuticals.
Biotech and pharmaceutical industry publication Endpoints News polled executives and leaders in the industry and found the vast majority, 87.6 %, oppose the ban and think it will have an impact on the industry.
After Trump made equivocal comments about who was to blame for violence at rallies held by white supremacists and neo-Nazis in Charlottesville over the weekend, Ken Frazier, the chief executive of pharmaceutical giant Merck, resigned from Trump's manufacturing council Monday.
Martin Shkreli, the Turing Pharmaceuticals LLC executive who drew criticism in August over a dramatic jump in a prescription drug price, made headlines Thursday for a different kind of price increase: a seven-fold surge in the shares of a microcap pharmaceutical company.
Long before Martin Shkreli was arrested in New York Thursday morning on securities fraud charges, the outspoken, 32 - year - old chief executive officer of Turing Pharmaceuticals AG had made himself famous.
Art has over 30 years of operating experience as a pharmaceutical and biotechnology industry executive and venture capital investor in life science companies.
Martin Shkreli, the chief executive of Turing Pharmaceuticals, explains the increase in drug prices in a CNBC interview.
In a 2014 deposition, the company's executive director of research and development said the pharmaceutical giant had no «procedure related to the development of what a drop size should be.»
Joaquin Duato, J&J's executive vice president and worldwide chairman of its pharmaceuticals segment, said earlier this year that the company intends to continue growing its pharma business in several ways.
CyberX invites you to a 1/2 day seminar, where you will network with your peers and hear CISOs and executives from leading organizations in the electricity, pharmaceutical and manufacturing sectors, share their experiences, challenges and what path they took to maximize operational resilience.
Prior to his career in executive search, Mr. Cummings was a consultant with The Boston Consulting Group in Dallas, where he worked on a wide variety of projects with clients in the aerospace & defense, consumer finance, telecommunications, oil & gas, pharmaceuticals, healthcare and education industries.
Kenneth C. Frazier, chief executive of Merck, the pharmaceuticals company, on Monday resigned from President Trump's American Manufacturing Council after the president failed to directly condemn the white nationalist protesters at the center of violent protests in Charlottesville, Va., over the weekend.
(Sen. Barack Obama, Remarks, Des Moines, IA, 1/3/08) in fact A list of Obama's own top fundraisers features a number of people involved in the business of influencing government, including the head of a lobbying and public relations firm, the corporate executive who oversees Comcast's lobbying efforts and the chairwoman of pharmaceutical giant Pfizer's political action committee, among others.»
A few months ago, BBC News suggested that «Martin Shkreli, the 32 - year - old chief executive of Turing Pharmaceuticals, may be the most hated man in America right now.»
Thorsten Kühn has been appointed the new Chief Executive Officer of the Schur Flexibles Group, a company based in Wiener Neudorf / Austria specialising in packaging solutions for the food, tobacco and pharmaceutical industries.
Dr. Smith, who assumed the role of Interim Chief Executive Officer in August 2016, brings over 20 years developing and managing product and business opportunities in the agricultural, human and animal nutrition, and pharmaceutical industries.
This good news has been welcomed by Steve Elliott, Chief Executive of the Association who said «These numbers, in the teeth of fierce global competition, reflect the hard work of chemical and pharmaceutical companies and their workforces» right across the UK».
Hundreds of overdose victims in Erie County are dead because major pharmaceutical companies misled doctors and patients into believing that highly addictive, prescription painkillers were safe, said Erie County Executive Mark Poloncarz, who is suing the companies in state Supreme Court.
Hundreds of overdose victims in Erie County are dead because major pharmaceutical companies misled doctors and patients into believing that highly addictive, prescription painkillers were safe, Erie County Executive Mark C. Poloncarz said.
Albany County Executive Dan McCoy and Elizabeth Smith of the South Carolina - based Motley Rice speak at a new conference about a lawsuit being against pharmaceutical companies for their alleged role in the opioid epidemic.
They cited three previous cases where courts ruled such questions are «relevant and probative» when they concern a defendant's actions in the context of a securities fraud prosecution, including that of pharmaceutical executive Martin Shkreli, whom Agnifilo represented.
«The pharmaceutical companies are in part responsible for this pandemic, and they need to help address what they helped to create,» said Stephanie Campbell, acting executive director of Friends of Recovery New York.
All said they would encourage the prosecution and jailing of bankers involved in the 2007 - 08 financial collapse, as well as pharmaceutical executives who have contributed to the opioid epidemic.
In recent years, billionaire pharmaceutical executives and hedge fund managers have made billions in profit by creating.In recent years, billionaire pharmaceutical executives and hedge fund managers have made billions in profit by creating.in profit by creating...
At Dominican College in Orangeburg on July 9, the Mid-Hudson EDC representatives met with Lt. Governor Robert Duffy, co-chairs Dennis Murray (President, Marist College) and Dr. Leonard Schleifer (President, Regeneron Pharmaceuticals) and Aimee Vargas, executive director of Mid-Hudson Empire State Development.
Today, at age 50, she's executive vice president of research and development at UCB, a major international pharmaceutical company in Slough, U.K.
This goal of this study, led by Geisbert and Ian MacLachlan, executive vice president and chief technical officer of Tekmira Pharmaceuticals, was to determine whether it is possible to protect animals against a lethal MARV - Angola infection when treatment was started at a point when animals have detectable levels of the virus in their system and show the first clinical signs of disease.
Activists often slam large pharmaceutical companies for failing to develop drugs that are of critical importance to the developing world.Andrew Witty, GlaxoSmithKline's youthful chief executive, gave those critics pause yesterday in a speech to the Council on Foreign Relations in New York City.Witty promised to sell the company's malaria vaccine that is in late - stage clinical trials in Africa for no more than a 5 percent profit.
«We see real promise in therapeutic strategies for SMA that increase production of the SMN protein,» said Muscular Dystrophy Association Executive Vice President Research and Medical Director Valerie Cwik, M.D. «We're delighted ISIS Pharmaceuticals is moving forward with a Phase 1 dose - escalation study of its antisense drug in children with SMA.»
Ms. Pace has nearly 20 years of communications, government affairs, patient advocacy, investor relations, program leadership and corporate planning experience in the biotech sector, including prior executive team roles at Agios Pharmaceuticals and Vertex Pharmaceuticals.
Before joining Gladstone, Mr. Moseley worked in the audit and assurance departments of Coopers & Lybrand and BDO Seidman, and as a financial executive at pharmaceutical and information technology firms.
Prior to Glaxo, Art was Vice President of Commercial Operations for Abbott International, and he held various executive and general management positions with Merrell Dow Pharmaceuticals and the Dow Chemical Company, in the United States and internationally.
Massimo also serves as Executive Chairman of Bioakos Pharma, a specialty pharmaceutical company based in Florence, Italy, and focused in the areas of dermatology, gynecology and pediatrics.
Art has over 30 years of operating experience as a pharmaceutical and biotechnology industry executive, and venture capital investor in life science companies.